Pure Solutions Appoints Catherine Osborne as Business Development Director

PRESS RELEASE

Pure Solutions Appoints Catherine Osborne as Business Development Director

CBE Pure Solutions (Pure Solutions), an Australian-owned biopharma manufacturing and testing company, is pleased to announce the appointment of Dr. Catherine Osborne as its new Business Development Director.

Pure Solutions specialises in the translation and manufacturing of clinical trials, specialty therapeutics, and microbiological testing. With a strong focus on innovation and growth, the company continues to expand its footprint in the healthcare and life sciences sector.

Catherine joins Pure Solutions from her most recent role as General Manager at LabConnect, bringing with her a wealth of experience in the clinical trial sector. She is a seasoned leader with a proven track record in creating business development opportunities and exceeding sales targets, leading high-performing teams, and delivering impactful solutions across the healthcare ecosystem. Catherine is particularly skilled at navigating complex stakeholder relationships and driving strategic growth.

In her new role, Catherine will focus on bridging the gap between concept and early-stage operations, working closely with industry partners to support the transformation of ideas into tangible outcomes.

“With Pure Solutions’ continued growth, Catherine was the standout candidate to support the business and expanding ecosystem,” said Justine Mann, CEO of Pure Solutions.

Catherine expressed her enthusiasm about the new role, stating she is looking forward to driving growth and collaborating closely with the talented team at Pure Solutions.